Our Services
Medical Information
Helpful Resources
Published on: 8/18/2026
In autosomal dominant conditions, only one altered copy of a gene is needed to cause a trait or disorder, so each child of an affected parent faces a 50 percent chance of inheriting it, independent of previous pregnancies or a child's sex. That 50 percent figure describes the odds of passing the variant, not the certainty of illness, because factors like penetrance, variable expressivity, age of onset, new spontaneous mutations, and anticipation can change how or whether symptoms appear. Several important details shape real world risk, including family history patterns and testing options, so see below to understand more.
If you are noticing symptoms and wondering whether an inherited condition could explain them, mapping what you feel is a practical first step before genetic counseling or lab work. A free, instant, online symptom check asks targeted questions about your symptoms and history, then suggests possible causes and the right type of clinician to see next. It takes only a few minutes, costs nothing, and gives you clearer language to bring to the appointment where inheritance risk can be evaluated properly.
Last reviewed for medical accuracy: 08/18/2026
When a parent carries an ALPL dominant negative variant, each child has a 50 percent chance of inheriting that altered gene. Understanding how this works can help you make informed decisions, recognize potential signs early, and seek appropriate care without undue anxiety.
Autosomal dominant inheritance means:
This “50 percent inheritance” concept applies to many conditions, including those caused by ALPL dominant negative variants.
The ALPL gene provides instructions for making an enzyme called tissue-nonspecific alkaline phosphatase (TNSALP). This enzyme plays a key role in:
When ALPL doesn’t work properly, it leads to hypophosphatasia (HPP), a condition with a wide spectrum of severity—from mild dental issues to life-threatening complications.
A dominant negative variant produces an altered protein that not only fails to do its job but also interferes with the normal protein from the healthy copy of the gene. Key points:
Every child of a parent with an ALPL dominant negative variant faces:
Not everyone who inherits an ALPL dominant negative variant experiences the same severity:
This variability makes genetic counseling and careful monitoring essential.
Early awareness can prompt timely evaluation and management. Common features include:
Bone and Joint
Muscle and Mobility
Other Systems
If you or a family member has unexplained bone issues or dental problems, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Steps to confirm an ALPL dominant negative variant:
Clinical Evaluation
– Detailed medical and family history
– Physical exam focusing on skeletal, dental, and neuromuscular signs
Laboratory Tests
– Alkaline phosphatase activity (often low in HPP)
– Levels of substrates that accumulate when TNSALP is low (e.g., phosphoethanolamine)
Genetic Testing
– Gene sequencing to identify ALPL variants
– Assessment of whether a variant is known or novel
– Interpretation by a genetics specialist to determine dominant negative impact
Genetic Counseling
– Explains inheritance risks (including the 50% chance per pregnancy)
– Discusses family planning options (e.g., prenatal testing, preimplantation genetic diagnosis)
While some forms of hypophosphatasia are severe, many people with a dominant negative variant lead active lives with proper care:
Treatment Options
Lifestyle and Monitoring
For those concerned about passing on an ALPL dominant negative variant:
Genetic counselors provide non-directive support to help you choose what feels right for your family.
Learning about a 50% inheritance risk can be unsettling. To stay balanced:
If you suspect you or your child may carry an ALPL dominant negative variant, act early:
Remember, this information is not a substitute for professional medical advice. If you experience severe pain, breathing difficulties, or any life-threatening symptoms, seek emergency care immediately. For any serious or persistent health concern, always speak to a doctor.
(References)
* Cousin MA, Creighton BA, Breau KA, Spillmann RC, Torti E, Dontu S, Tripathi S, Ajit D, Edwards RJ, Afriyie S, Bay JC, Harper KM, Beltran AA, Munoz LJ, Falcon Rodriguez L, Stankewich MC, Person RE, Si Y, Normand EA, Blevins A, May AS, Bier L, Aggarwal V, Mancini GMS, van Slegtenhorst MA, Cremer K, Becker J, Engels H, Aretz S, MacKenzie JJ, Brilstra E, van Gassen KLI, van Jaarsveld RH, Oegema R, Parsons GM, Mark P, Helbig I, McKeown SE, Stratton R, Cogne B, Isidor B, Cacheiro P, Smedley D, Firth HV, Bierhals T, Kloth K, Weiss D, Fairley C, Shieh JT, Kritzer A, Jayakar P, Kurtz-Nelson E, Bernier RA, Wang T, Eichler EE, van de Laar IMBH, McConkie-Rosell A, McDonald MT, Kemppainen J, Lanpher BC, Schultz-Rogers LE, Gunderson LB, Pichurin PN, Yoon G, Zech M, Jech R, Winkelmann J, Undiagnosed Diseases Network, Genomics England Research Consortium, Beltran AS, Zimmermann MT, Temple B, Moy SS, Klee EW, Tan QK, Lorenzo DN. Pathogenic SPTBN1 variants cause an autosomal dominant neurodevelopmental syndrome. Nat Genet. 2021 Jul;53(7):1006-1021. doi: 10.1038/s41588-021-00886-z. Epub 2021 Jul 1. PMID: 34211179; PMCID: PMC8273149.
* Zhang J, Walsh MF, Wu G, Edmonson MN, Gruber TA, Easton J, Hedges D, Ma X, Zhou X, Yergeau DA, Wilkinson MR, Vadodaria B, Chen X, McGee RB, Hines-Dowell S, Nuccio R, Quinn E, Shurtleff SA, Rusch M, Patel A, Becksfort JB, Wang S, Weaver MS, Ding L, Mardis ER, Wilson RK, Gajjar A, Ellison DW, Pappo AS, Pui CH, Nichols KE, Downing JR. Germline Mutations in Predisposition Genes in Pediatric Cancer. N Engl J Med. 2015 Dec 10;373(24):2336-2346. doi: 10.1056/NEJMoa1508054. Epub 2015 Nov 18. PMID: 26580448; PMCID: PMC4734119.
* Piotrowski A, Xie J, Liu YF, Poplawski AB, Gomes AR, Madanecki P, Fu C, Crowley MR, Crossman DK, Armstrong L, Babovic-Vuksanovic D, Bergner A, Blakeley JO, Blumenthal AL, Daniels MS, Feit H, Gardner K, Hurst S, Kobelka C, Lee C, Nagy R, Rauen KA, Slopis JM, Suwannarat P, Westman JA, Zanko A, Korf BR, Messiaen LM. Germline loss-of-function mutations in LZTR1 predispose to an inherited disorder of multiple schwannomas. Nat Genet. 2014 Feb;46(2):182-7. doi: 10.1038/ng.2855. Epub 2013 Dec 22. PMID: 24362817; PMCID: PMC4352302.
* Lohmann D. Retinoblastoma. Adv Exp Med Biol. 2010;685:220-7. doi: 10.1007/978-1-4419-6448-9_21. PMID: 20687510.
* Saleh S, Beyyumi E, Al Kaabi A, Hertecant J, Barakat D, Al Dhaheri NS, Al-Gazali L, Al Shamsi A. Spectrum of neuro-genetic disorders in the United Arab Emirates national population. Clin Genet. 2021 Nov;100(5):573-600. doi: 10.1111/cge.14044. Epub 2021 Aug 19. PMID: 34374989.
* Niederau C. [Hereditary hemochromatosis]. Med Klin (Munich). 2009 Dec 15;104(12):931-46. doi: 10.1007/s00063-009-1192-6. PMID: 20039160.
* Almaani N, Liu L, Dopping-Hepenstal PJ, Lai-Cheong JE, Wong A, Nanda A, Moss C, Martinéz AE, Mellerio JE, McGrath JA. Identical glycine substitution mutations in type VII collagen may underlie both dominant and recessive forms of dystrophic epidermolysis bullosa. Acta Derm Venereol. 2011 May;91(3):262-6. doi: 10.2340/00015555-1053. PMID: 21448560.
* Gallion HH, Smith SA. Hereditary ovarian carcinoma. Semin Surg Oncol. 1994 Jul-Aug;10(4):249-54. doi: 10.1002/ssu.2980100404. PMID: 8091066.
* Engelborghs S, D'Hooge R, De Deyn PP. Pathophysiology of epilepsy. Acta Neurol Belg. 2000 Dec;100(4):201-13. PMID: 11233674.
* Klein AP, Hruban RH, Brune KA, Petersen GM, Goggins M. Familial pancreatic cancer. Cancer J. 2001 Jul-Aug;7(4):266-73. PMID: 11561603.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.